229 related articles for article (PubMed ID: 23043153)
1. Enhanced angiotensin II-induced cardiac and aortic remodeling in ACE2 knockout mice.
Alghamri MS; Weir NM; Anstadt MP; Elased KM; Gurley SB; Morris M
J Cardiovasc Pharmacol Ther; 2013 Mar; 18(2):138-51. PubMed ID: 23043153
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling.
Patel VB; Zhong JC; Fan D; Basu R; Morton JS; Parajuli N; McMurtry MS; Davidge ST; Kassiri Z; Oudit GY
Hypertension; 2014 Jul; 64(1):157-64. PubMed ID: 24799609
[TBL] [Abstract][Full Text] [Related]
3. Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit.
Bodiga S; Zhong JC; Wang W; Basu R; Lo J; Liu GC; Guo D; Holland SM; Scholey JW; Penninger JM; Kassiri Z; Oudit GY
Cardiovasc Res; 2011 Jul; 91(1):151-61. PubMed ID: 21285291
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
[TBL] [Abstract][Full Text] [Related]
5. ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production.
Jin HY; Song B; Oudit GY; Davidge ST; Yu HM; Jiang YY; Gao PJ; Zhu DL; Ning G; Kassiri Z; Penninger JM; Zhong JC
PLoS One; 2012; 7(6):e38502. PubMed ID: 22693641
[TBL] [Abstract][Full Text] [Related]
6. Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction.
Kassiri Z; Zhong J; Guo D; Basu R; Wang X; Liu PP; Scholey JW; Penninger JM; Oudit GY
Circ Heart Fail; 2009 Sep; 2(5):446-55. PubMed ID: 19808375
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy.
Feng Y; Hans C; McIlwain E; Varner KJ; Lazartigues E
PLoS One; 2012; 7(11):e48910. PubMed ID: 23155428
[TBL] [Abstract][Full Text] [Related]
8. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
[TBL] [Abstract][Full Text] [Related]
9. Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension.
Wysocki J; Ye M; Rodriguez E; González-Pacheco FR; Barrios C; Evora K; Schuster M; Loibner H; Brosnihan KB; Ferrario CM; Penninger JM; Batlle D
Hypertension; 2010 Jan; 55(1):90-8. PubMed ID: 19948988
[TBL] [Abstract][Full Text] [Related]
10. Interaction of diabetes and ACE2 in the pathogenesis of cardiovascular disease in experimental diabetes.
Tikellis C; Pickering R; Tsorotes D; Du XJ; Kiriazis H; Nguyen-Huu TP; Head GA; Cooper ME; Thomas MC
Clin Sci (Lond); 2012 Oct; 123(8):519-29. PubMed ID: 22616805
[TBL] [Abstract][Full Text] [Related]
11. Sex-Specific Modulation of Blood Pressure and the Renin-Angiotensin System by ACE (Angiotensin-Converting Enzyme) 2.
Ji H; de Souza AMA; Bajaj B; Zheng W; Wu X; Speth RC; Sandberg K
Hypertension; 2020 Aug; 76(2):478-487. PubMed ID: 32564694
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart.
Mercure C; Yogi A; Callera GE; Aranha AB; Bader M; Ferreira AJ; Santos RA; Walther T; Touyz RM; Reudelhuber TL
Circ Res; 2008 Nov; 103(11):1319-26. PubMed ID: 18845809
[TBL] [Abstract][Full Text] [Related]
13. Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice.
Zhang ZZ; Shang QH; Jin HY; Song B; Oudit GY; Lu L; Zhou T; Xu YL; Gao PJ; Zhu DL; Penninger JM; Zhong JC
J Transl Med; 2013 Sep; 11():229. PubMed ID: 24067190
[TBL] [Abstract][Full Text] [Related]
14. Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.
Jin HY; Chen LJ; Zhang ZZ; Xu YL; Song B; Xu R; Oudit GY; Gao PJ; Zhu DL; Zhong JC
J Transl Med; 2015 Aug; 13():255. PubMed ID: 26245758
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro.
Haber PK; Ye M; Wysocki J; Maier C; Haque SK; Batlle D
Hypertension; 2014 Apr; 63(4):774-82. PubMed ID: 24446061
[TBL] [Abstract][Full Text] [Related]
16. Heterozygote loss of ACE2 is sufficient to increase the susceptibility to heart disease.
Wang W; Patel VB; Parajuli N; Fan D; Basu R; Wang Z; Ramprasath T; Kassiri Z; Penninger JM; Oudit GY
J Mol Med (Berl); 2014 Aug; 92(8):847-58. PubMed ID: 24728465
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice.
Patel VB; Bodiga S; Fan D; Das SK; Wang Z; Wang W; Basu R; Zhong J; Kassiri Z; Oudit GY
Hypertension; 2012 Jun; 59(6):1195-203. PubMed ID: 22508831
[TBL] [Abstract][Full Text] [Related]
18. Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice.
Gurley SB; Allred A; Le TH; Griffiths R; Mao L; Philip N; Haystead TA; Donoghue M; Breitbart RE; Acton SL; Rockman HA; Coffman TM
J Clin Invest; 2006 Aug; 116(8):2218-25. PubMed ID: 16878172
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats.
Trask AJ; Groban L; Westwood BM; Varagic J; Ganten D; Gallagher PE; Chappell MC; Ferrario CM
Am J Hypertens; 2010 Jun; 23(6):687-93. PubMed ID: 20300067
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme 2 deficiency is associated with impaired gestational weight gain and fetal growth restriction.
Bharadwaj MS; Strawn WB; Groban L; Yamaleyeva LM; Chappell MC; Horta C; Atkins K; Firmes L; Gurley SB; Brosnihan KB
Hypertension; 2011 Nov; 58(5):852-8. PubMed ID: 21968754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
